Oppenheimer's Healthcare Investment Banking Group draws on extensive industry knowledge, execution experience and the capabilities of a full service financial institution to assist our clients to grow and adapt in today's dynamic global business environment.
We have significant experience as buyside and sellside transaction advisors as well as in underwriting equity and debt offerings. Our team maintains active relationships with institutional investors and financial sponsors. Over the last decade, Oppenheimer's healthcare banking professionals have advised on approximately 300 deals including advisory services for transactions totaling approximately $13 billion and financings totaling approximately $30 billion*.
We are particularly focused on the following sub-sectors:
Biotechnology Specialty Pharmaceuticals and Generics
Healthcare Information Technology
Medical Devices Life Science Tools and Diagnostics
*Includes some transactions completed prior to Oppenheimer's acquisition in January 2008 of certain of CIBC World Markets' investment banking and capital markets businesses in the U.S., Israel, Europe and Asia.